RenalGuard® demonstrated a 52% reduction in AKI vs. standard of care

  • The KIDNEY study is a 220-patient (on-pump) randomized controlled study
  • 110 patients in each arm (RenalGuard Therapy vs. standard of care).
  • Study conducted at a leading hospital in the UK.
  • The number needed to treat (NNT) with the RenalGuard system to prevent AKI was 9 patients.

RenalGuard Prevents AKI in Cardiac Surgery

Automated Fluid Management System

Continuous Diuresis and Balanced Rehydration

Before, During, and After Surgery